Tips for Pharmaceutical Manufacturing Scale-Up & Tech Transfer

Mitigating Risks of Regulatory Filing During Technology Transfer In the pharmaceutical industry, the technology transfer process is critical for ensuring that manufacturing methods and product formulations are effectively transferred between…

During technology transfers, several indicators may suggest issues impacting regulatory filings: Click to read the full article.

Identifying early symptoms that signal a potential issue during the manufacturing scale-up process is crucial. Here are some common indicators:Click to read the full article.

Recognizing early symptoms of issues during equipment scale-up is essential for averting regulatory challenges. Common signals that may indicate potential problems include:Click to read the full article.

During a routine quality assurance review, discrepancies in process validation records surfaced, signaling potential issues with the scale-up and site transfer. Symptoms included:Click to read the full article.

In this case, the problem became evident during routine post-production quality checks, where deviations in critical quality attributes (CQAs) were detected in batches processed at the new facility. The most…

Identifying the right signals is crucial for detecting potential issues during the scale-up process and ensuring that regulatory requirements are met. Common symptoms and signals within the manufacturing or laboratory…

Identifying failure signals early can mitigate the risk of delays and ensure compliance during the scale-up process. Key symptoms include:Click to read the full article.

Manufacturing teams often encounter various symptoms that signal potential issues with CMC submissions. Recognizing these signals early on can mitigate risks. Common indicators include:Click to read the full article.

Before considering a batch size increase, it's critical to understand the signals indicating the need for change. Look for the following symptoms:Click to read the full article.

The first indication that there may be an issue with process parameters during scale-up often comes from observing symptoms or signals on the production floor or within the lab. These…

During the scale-up process, several symptoms may indicate potential regulatory implications due to changes in process parameters. Common signs include:Click to read the full article.